A leading scientific publication deems stems cells to be its breakthrough of the year. And an industrious research head jumps on the bandwagon, laying the groundwork for some of the most significant research done in this area - research that is now actively supported by both government and private interests.
In 1999, Science magazine declared the newly emerging
therapeutic promise of embryonic stem cells - the
cells that give rise to all the organs in the
developing fetus - to be its breakthrough of the
year.
And, in so doing, quite unintentionally unleashed a
research tidal wave in Ottawa.
That is because Ron Worton, then recently appointed
head of research at what is now the Ottawa Health
Research Institute, had been considering how to
reconfigure his institution's efforts. What he was
looking for was a major theme to focus on, something
that would galvanize interest on the inside and draw
attention and funding from the outside.
He had been considering stem cells, which he had
studied in the 1960s in the lab of their
Toronto-based discoverers, Ernest McCulloch and James
Till.
But even though it was known for decades that stem
cells act as a repair system for the mature body, the
persistent difficulties in obtaining viable cells led
to a basic problem. Stem cells had slid to the bottom
of almost everyone's research agenda.
But when Science magazine anointed the cells'
promise, Worton had what he calls his "bingo moment."
"I said, 'Okay, that sort of confirms all of the
things that I've been thinking about.' I walked over
to my colleagues on the floor and I said, 'Okay, that
should be our next big wave of activity. We can build
something around this,'" he recalls.
What he wanted was not just research, but therapeutic
applications. And what he got? Consider the
following.
On the research front, Worton was the initial
scientific director of the Stem Cell Network - a
network that linked 80 researchers across the
country. They had been looking at potential therapies
for the gamut of diseases where cells fail or
malfunction; for example, cancer, type 1 diabetes,
heart and lung disease, stroke, spinal cord injury
and more.
In 2005, this mantle was passed on to Michael
Rudnicki, who had been recruited from McMaster
University to head up stem cell research at the
hospital. On Worton's behalf, Rudnicki and his
colleagues began to take a long, hard look at the
fundamental mechanisms that trigger stem cells and
allow them to complete their repair efforts. One
quite promising result has been the research that has
grown out of a transgenic mouse that was engineered
to have an exceptionally thin-walled and poorly
functioning heart.
Reasoning that this is exactly the kind of defect
that stem cells were designed to correct, Rudnicki's
laboratory moved on to discover stem cells in adult
muscle and were able to define the genes that are
important for muscle regeneration.
However, by far the most spectacular results made
have been the work of Harry Atkins with multiple
sclerosis, a disease in which the body's immune
system attacks and destroys the brain and spinal
cord.
What Atkins did was purify and freeze patients' bone
marrow stem cells and then destroy their old immune
system with chemotherapy. The stem cells were then
re-implanted with the hope they would eventually form
a new immune system.
In almost all cases, stem cells have slowed or halted
the progression of the disease, and in one woman
apparently reversed it entirely.
And there also has been a very different kind of
success. The almost daily discussions in the media of
the possibilities of stem cell therapy combined with
what is the Ottawa Health Research Institute's skill
in expanding these possibilities have inspired a
flood of private donations from people wanting to
associate themselves with stem cell therapies.
The most notable is a $7 million donation to support
operating costs from Eric and Vizma Sprott, after
whom the OHRI stem cell research centre is now
named.
But they are not the only ones lending support.
"People understand that the kind of research going on
here is going to be part of their future," says
Duncan Stewart, who in 2007 took over from
Worton.
"And if they have the means, they want to make that
future happen faster."
Worton nods and adds a mantra that was true when he
moved his institution into stem cell research and is
even truer today: "Success creates excitement."
